跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Goglitazone 15 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Goglitazone 15
Approved
STANDARD
Goglitazone 15
Umedica Laboratories Pvt. Ltd
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
27ad4389f347308a
Company
Umedica Laboratories Pvt. Ltd
Type
Standard
Approval Details
Approval Id
27ad4389f347308a
Drug Approval Philippines Name
Goglitazone 15
Product Name
Goglitazone 15
Registration Number
DRP-1183-03
Brand Name
Goglitazone 15
Generic Name
Pioglitazone (as hydrochloride)
Dosage Form
Tablet
Dosage Strength
15 mg
Manufacturer
Umedica Laboratories Pvt. Ltd
Importer
Suhitas Pharmaceuticals Inc
Distributor
Applied Pharmaceutical Distribution Inc
Issuance Date
24 April 2024
Expiry Date
16 December 2028
Pharmacologic Category
Blood Glucose Lowering Drug (Thiazolidinedione)
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
27ad4389f347308a
Type
Standard
Back to Philippines FDA Approvals